Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-RM2 PET/MRI for Recurrent Prostate Cancer
NCT02624518Phase 3Completed
- Sponsor
- Andrei Iagaru
- Start
- Nov 2015
- Primary completion
- Jul 2021
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of 68Ga-DOTA-Bombesin in prostate cancer (PCa), sponsored by Andrei Iagaru. Started Nov 2015; status: completed.
02
Drugs
68Ga-DOTA-Bombesin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT02624518.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02624518.